Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -79.15%9.34M | 48.33%7.75M | 471.37%4.21M | -77.54%3.35M | -124.91%-5.97M | 126.68%44.81M | 558.06%5.23M | 256.04%737K | 235.79%14.9M | 67.13%23.95M |
| Net profit before non-cash adjustment | -8.59%-18.64M | 60.08%-7.48M | -117.93%-4.76M | -184.58%-2.75M | -804.26%-3.64M | -226.09%-17.16M | -1,700.60%-18.74M | -326.06%-2.19M | 161.59%3.25M | 124.34%517K |
| Total adjustment of non-cash items | -15.23%8.48M | -23.16%7.06M | 175.00%638K | 45.98%381K | 24.61%400K | -38.96%10M | -26.76%9.19M | 103.56%232K | -95.34%261K | -93.25%321K |
| -Depreciation and amortization | 15.88%489K | 2.50%123K | 14.41%135K | 14.81%124K | 40.79%107K | 26.73%422K | 53.85%120K | 42.17%118K | 27.06%108K | -12.64%76K |
| -Reversal of impairment losses recognized in profit and loss | --1.67M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Assets reserve and write-off | -92.95%652K | -99.91%8K | --325K | --171K | --148K | 2.62%9.25M | --9.25M | --0 | --0 | --0 |
| -Disposal profit | --0 | -86.05%6K | --0 | --0 | ---6K | 400.00%30K | 100.74%43K | --0 | ---13K | --0 |
| -Other non-cash items | 1,809.09%5.67M | 2,404.82%5.26M | 56.14%178K | -48.19%86K | -38.37%151K | -96.44%297K | -102.16%-228K | 101.56%114K | -63.52%166K | -94.75%245K |
| Changes in working capital | -62.48%19.5M | -44.71%8.17M | 209.81%8.34M | -49.82%5.71M | -111.79%-2.72M | 501.30%51.97M | 304.72%14.78M | 5,282.00%2.69M | 176.68%11.39M | 97.61%23.11M |
| -Change in receivables | -66.62%13.89M | -303.13%-15.31M | 215.58%5.89M | -93.21%2.67M | 84.19%20.65M | 249.63%41.62M | 70.96%-3.8M | 48.56%-5.1M | 402.89%39.31M | 37.68%11.21M |
| -Change in inventory | -66.86%20.13M | 7.17%26.94M | -128.94%-4.35M | 769.76%11.34M | -162.04%-13.8M | 14.70%60.73M | -43.03%25.14M | 377.82%15.04M | -115.68%-1.69M | 546.19%22.24M |
| -Change in payables | 66.37%-13.83M | -202.33%-2.77M | 193.72%6.8M | 68.38%-8.29M | 7.43%-9.57M | -36.29%-41.12M | 105.20%2.7M | -147.22%-7.26M | -516.53%-26.23M | -9,332.14%-10.34M |
| -Changes in other current assets | 92.52%-693K | ---- | ---- | ---- | ---- | -167.70%-9.27M | ---- | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 384.16%3.84M | 712.48%4.17M | 219.65%341K | -11.16%-269K | -182.52%-404K | -1,522.11%-1.35M | -1,521.43%-681K | -2,292.31%-285K | -199.18%-242K | -19.17%-143K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -69.67%13.18M | 162.35%11.92M | 907.08%4.55M | -79.01%3.08M | -126.75%-6.37M | 118.80%43.46M | 504.26%4.54M | 105.45%452K | 176.76%14.66M | 75.12%23.81M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 94.59%-172K | -137.93%-11K | -600.00%-14K | 99.68%-10K | -163.46%-137K | -13,717.39%-3.18M | 422.22%29K | 90.00%-2K | -28,763.64%-3.15M | -940.00%-52K |
| Net investment product transactions | --0 | 0.00%12K | 80.00%-4K | 83.61%-10K | -85.71%2K | -147.41%-55K | 9.09%12K | -217.65%-20K | -212.96%-61K | -58.82%14K |
| Interest received (cash flow from investment activities) | -13.03%534K | -14.20%290K | -54.95%41K | 31.07%135K | -17.07%68K | -0.49%614K | -12.21%338K | 4.60%91K | 45.07%103K | 10.81%82K |
| Investing cash flow | 113.82%362K | -23.22%291K | -66.67%23K | 103.70%115K | -252.27%-67K | -468.87%-2.62M | -2.07%379K | -17.86%69K | -2,387.50%-3.11M | -57.28%44K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | 77.37%-3.68M | --0 | 166.57%7.71M | -146.35%-7.83M | 75.31%-3.55M |
| Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | -850.95%-9.5M | --0 | -100.00%-2M | --0 | ---7.5M |
| Increase or decrease of lease financing | -176.14%-243K | -563.64%-73K | -227.27%-72K | -115.15%-71K | -22.73%-27K | ---88K | ---11K | ---22K | ---33K | ---22K |
| Interest paid (cash flow from financing activities) | 20.57%-6.22M | 45.25%-1.53M | 51.33%-1.55M | -840.72%-1.57M | 6.62%-1.57M | -17.40%-7.83M | -55.62%-2.8M | -75.23%-3.19M | 93.15%-167K | -172.52%-1.68M |
| Net other fund-raising expenses | 53.32%-2.35M | -103.48%-103K | 99.90%-3K | 121.62%540K | -10.45%-2.78M | -195.06%-5.02M | 232.99%2.96M | -132.34%-2.97M | -94.40%-2.5M | -553.51%-2.52M |
| Financing cash flow | 66.27%-8.81M | -1,238.67%-1.71M | -246.38%-1.63M | 89.54%-1.1M | 71.37%-4.37M | -40.20%-26.12M | 102.68%150K | -105.08%-470K | -52.59%-10.53M | 0.81%-15.27M |
| Net cash flow | ||||||||||
| Beginning cash position | 376.50%18.63M | -5.14%12.86M | -26.60%9.91M | -37.37%7.82M | 376.50%18.63M | 98.78%3.91M | 62.20%13.56M | 1,228.40%13.51M | 4,476.19%12.49M | 98.78%3.91M |
| Current changes in cash | -67.84%4.73M | 107.06%10.5M | 5,678.43%2.95M | 106.11%2.09M | -225.91%-10.81M | 657.64%14.72M | 214.03%5.07M | -99.47%51K | 168.98%1.01M | 606.67%8.58M |
| End cash Position | 25.41%23.37M | 25.41%23.37M | -5.14%12.86M | -26.60%9.91M | -37.37%7.82M | 376.50%18.63M | 376.50%18.63M | 62.20%13.56M | 1,228.40%13.51M | 4,476.19%12.49M |
| Free cash flow | -67.65%13.01M | 164.10%11.92M | 908.44%4.54M | -73.36%3.06M | -127.39%-6.51M | 102.85%40.21M | 508.91%4.51M | 125.00%450K | 117.18%11.49M | 74.80%23.76M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.